Judith R. Abrams serves as Executive at Editas Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Judith R. Abrams has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 28, 2019 involved receiving (via award) 25,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 28, 2019 | EDIT | $0 | Award | 25,000 | $N/A | Discretionary |
Judith R. Abrams currently holds 25,000 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Judith R. Abrams has been a net neutral trader of EDIT stock. They have purchased $0 and sold $0 worth of shares.
Judith R. Abrams's most recent insider trade was on Oct 28, 2019, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted